DIRECTORATE
OF OUTPATIENTS SERVICES POLICY
FOR THE PREVENTION OF REGULAR USE OF CHEMOTHERAPY REGIMENS NOT ON THE
APPROVED LIST The
designated location for the administration of outpatient intravenous
chemotherapy for the trust is the Haematology Day Unit which is located on
Mary Seacole Ward. All
outpatient chemotherapy must be administered according to the procedures
laid down in the Guidelines for the Safe Handling of Cytotoxic Drugs
(B&TGH) enclosed herein. There
is an approved list of chemotherapy regimens to be used in the South Essex
Cancer Network. The list for
haematological cancer only is applicable to the Basildon site. –
A copy of the most recent list is available from Dr Paul Cervi,
Lead Clinician For Chemotherapy Services for B+T NHS Trust.
A copy is also held in the Medicines Information Centre, Basildon
Hospital. Any
prescription for intravenous chemotherapy, which is not on the approved
list should be confirmed with the prescriber and the prescriber informed
that the regimen is not on the approved list.
If the prescriber wishes to proceed with the prescription, the lead
clinician for Chemotherapy services, Dr Paul Cervi and the pharmacy
manager, Mr Peter Croot, should be informed immediately. Chemotherapy
not on the approved list should not be prepared and issued without the
agreement of the lead clinician for chemotherapy services – or in his
absence the Pharmacy Manager. Any
concerns should be referred to the D+T chair. Further use of the regime
must have the approval of the Chemotherapy committee before it can be
re-supplied. Chemotherapy
not on the approved list and prescribed by the lead clinician for
chemotherapy services require the authorization of the Chairman of the
D&T committee. More
than the first use of a chemotherapy regimen – not on the approved list
– must be accompanied by written evidence that the regimen has been
submitted to the chemotherapy subcommittee of the B&T D&T
committee and the South Essex Haematology Cancer Steering Group for
approval and addition to the approved list. Signed:
……………………………………….
Date:…………………..
Dr Paul Cervi
Lead Clinician for Chemotherapy services Signed:
……………………………………….
Date:…………………..
Mr Peter Croot
Pharmacy Manager Signed: ……………………………………….
Date:…………………..
Dr Ian Barton,
Chairman B&T D&T Committee. Signed: ……………………………………….
Date:…………………..
Dr E Watts, Clinical Director, Clinical Sciences including pharmacy services. |
||
top |